Clinical Trial Update: Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study update for hydromorphone combined with electroacupuncture and ear acupoint pressing to treat refractory cancer pain, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Qinghai Red Cross Hospital | Conditions: Refractory Cancer Pain, Cancer Pain | EARLY_Phase 1 | Status: NOT_YET_RECRUITING